1 | 12:30-12:35 |
开场致辞 |
|
||||||
2 | 12:35-12:50 |
UAB专家共识 |
|
||||||
3 | 12:50-13:05 |
女性排尿困难诊治中国专家共识 |
|
||||||
4 | 13:05-13:20 |
始于机制,践于临床--探究多沙唑嗪在BPH/LUTS中的应用 |
|
||||||
5 | 13:20-13:30 |
总结致辞 |
|
1 | 13:25-13:28 |
大会主席开幕致辞 |
|
||||
2 | 13:28-13:32 |
上海医学会泌尿外科分会主任委员致辞 |
|
||||
3 | 13:32-13:36 |
中华医学会泌尿外科学分会副主任委员致辞 |
|
||||
4 | 13:36-13:40 |
上海市长宁区卫健委主任致辞 |
|
1 | 13:40-13:46 |
全尿道悬吊联合后盆底重建术治疗女性压力性尿失禁伴阴道松弛症术后性功能的改善效果研究 |
|
||||
2 | 13:46-13:52 |
基于全流程自动化膀胱分割与膀胱形态特征提取的上尿路功能障碍风险评估 |
|
||||
3 | 13:52-13:58 |
倒Y型保留功能尿道钬激光激光前列腺剜除术对术后尿失禁的影响 |
|
||||
4 | 13:58-14:04 |
膀胱内注射富血小板血浆对盆腔手术后尿潴留的潜在治疗手段 |
|
||||
5 | 14:04-14:10 |
改良式膀胱内电刺激改善脊髓损伤致神经源性膀胱患者排尿困难的相关研究 |
|
||||
6 | 14:10-14:15 |
讨论 |
1 | 14:15-14:22 |
从指南到临床:人工尿道括约肌在前列腺肿瘤术后尿控功能恢复 |
|
||||
2 | 14:22-14:30 |
Rezum手术经验与思考 |
|
1 | 14:30-14:36 |
女性宫颈癌放疗后并发膀胱阴道瘘的临床处理方法 |
|
||||
2 | 14:36-14:42 |
骶神经调控治疗神经源性膀胱合并膀胱输尿管反流的长期疗效:单中心回顾性研究 |
|
||||
3 | 14:42-14:48 |
人工智能分割技术对前列腺癌精准手术中尿控功能的影响研究 |
|
||||
4 | 14:48-14:54 |
生理性重建术治疗中重度盆底器官脱垂的效果评估:一项自身对照、多中心回顾性研究 |
|
||||
5 | 14:54-15:00 |
自体单采富血小板血浆联合骶神经调控治疗原发性膀胱疼痛综合征合并膀胱活动低下的有效性和安全性 |
|
||||
6 | 15:00-15:05 |
讨论 |
1 | 15:05-15:20 |
女性尿失禁手术技术全球新进展 |
|
1 | 15:20-15:26 |
仿生水凝胶模型揭示间质性膀胱炎炎症-纤维化机制的研究 |
|
||||
2 | 15:26-15:32 |
基于强化感知的全程PFME方案在LRP患者早期尿控恢复中的应用研究 |
|
||||
3 | 15:32-15:38 |
阴道触觉成像在女性盆底疾病中的应用:现状与展望 |
|
||||
4 | 15:38-15:44 |
女性控尿机制:基于动态生物力学平衡 |
|
||||
5 | 15:44-15:50 |
非侵入数字化排尿图Q-v测定520例病人排尿功能评估 |
|
||||
6 | 15:50-15:55 |
讨论 |
1 | 15:55-16:10 |
压力性尿失禁新技术及新书介绍 |
|
1 | 16:10-16:16 |
B超联合尿动力检查在神经源性膀胱患者中的应用 |
|
||||
2 | 16:16-16:22 |
骶神经调控Stage1术中零辐射新技术的探索与验证-B超引导下电极置入技术在动物实验中的应用与效果评估 |
|
||||
3 | 16:22-16:28 |
女性压力性尿失禁的流固耦合生物力学机制研究 |
|
||||
4 | 16:28-16:34 |
非侵入性盆底物理振动按摩治疗女性功能性障碍性排尿的初步研究 |
|
||||
5 | 16:34-16:40 |
膀胱平滑肌组织共培养对小鼠盆神经节出芽的影响 |
|
||||
6 | 16:40-16:45 |
讨论 |
1 | 16:45-17:00 |
一种植物药在治疗良性前列腺增生症的临床价值探索 |
|
1 | 17:00-17:06 |
尿液刺激下回肠功能的适应性变化 |
|
||||
2 | 17:06-17:12 |
影像尿动力在重度反流性肾积水假性残余尿增多的鉴别诊断 |
|
||||
3 | 17:12-17:18 |
骶神经调控手术患者围手术期焦虑抑郁情绪的危险因素及对手术疗效的影响分析 |
|
||||
4 | 17:18-17:24 |
间质性膀胱炎的氧化应激机制及其治疗策略 |
|
||||
5 | 17:24-17:30 |
基于膀胱安全容量的间歇导尿技术在神经源性膀胱行骶神经调控患者中的应用研究 |
|
||||
6 | 17:30-17:35 |
讨论 |
1 | 17:45-18:00 |
间歇性导尿临床应用中国专家共识解读 |
|
1 | 08:00-08:05 |
Welcome Music |
|||||||
2 | 08:05-08:10 |
Welcome Address(President of 2025 PPCS, President of the CCS) |
|
||||||
3 | 08:10-08:15 |
Welcome Speech(President of the CUA) |
|
||||||
4 | 08:15-08:20 |
Presentation of Appreciation Certificates for "Handbook of Neurourology" |
|
||||||
5 | 08:20-08:25 |
Acknowledgement with Book Presentation for Societies from PPCS |
|||||||
6 | 08:25-08:35 |
Group Photo |
1 | 08:30-09:00 |
Neurourology: the Past, Present and Future |
|
||||
2 | 09:00-09:30 |
OAB: the Past, Present and Future |
|
||||
3 | 09:30-10:00 |
Lower Urinary Tract Symptoms: Is It Time for a New Paradigm? |
|
1 | 10:00-10:20 |
State-of-the-Art Lecture: Neuromodulation in Lower Urinary Tract Dysfunction: What is New? |
|
||||
2 | 10:20-10:40 |
State-of-the-Art Lecture: Lower Urinary Tract Dysfunction Related with Chronic Ischemia |
|
||||
3 | 10:40-11:00 |
State-of-the-Art Lecture:Management of Failed Mid-urethral Sling Operation |
|
1 | 11:00-11:10 |
Innovations and Advances in the Treatment of Complex Posterior Urethral Strictures |
|
||||
2 | 11:10-11:20 |
The End Stage Bladder and Outlet: Managed by Robotic Cystectomy and Diversion |
|
||||
3 | 11:20-11:30 |
China Multi-Center LUTS Baseline Study and Real-World Research Database Construction |
|
||||
4 | 11:30-11:40 |
Development of Near-Infrared Spectroscopy Based Wearable Bladder Monitoring System for Neurogenic Bladder: Preclinical study. |
|
||||
5 | 11:40-11:50 |
Urodynamic Studies Cannot Predict Post-micturition Dribbling in Surgery-naive Men with Lower Urinary Tract Symptoms |
|
||||
6 | 11:50-12:00 |
The Effects of Combination Therapy with Electroacupuncture and Pelvic Floor Muscle Training on Stress Urinary Incontinence Following Radical Prostatectomy: the Report from a Randomized Controlled Trial |
|
1 | 12:00-12:15 |
The Diagnosis and Treatment of Nocturia |
|
||||
2 | 12:15-12:30 |
The New Era of SNM technology- Introduction of the MRI-Compatible, Long-lasting and Recharge-Free Technology in Clinical Practice |
|
||||
3 | 12:30-12:40 |
Ambulatory Urinary Function Monitoring Using Flexible Pressure Sensors: From Validation to Commercialization |
|
1 | 13:30-13:40 |
From Following to Leading: The Development of Pediatric Urodynamics in China and Its Global Contributions |
|
||||
2 | 13:40-13:50 |
Comparing The Clinical Outcomes and Learning Curves of Prostatic Urethral Lift Performed By Experienced Versus Naïve Urologists |
|
||||
3 | 13:50-14:00 |
Brain Prostaglandin E2 Suppresses the Rat Micturition Reflex |
|
||||
4 | 14:00-14:10 |
Efficacy and Cost-Effectiveness Analysis of Third-Line Oab Management in A Tertiary Public Hospital |
|
||||
5 | 14:10-14:20 |
Transurethral Enucleation with Bipolar Energy for Benign Prostate Hypertrophy: Assessing Surgical Outcomes in Patients with and without Neurologic Deficits. |
|
||||
6 | 14:20-14:30 |
Thromboxane A2 in The Central Nervous System Facilitates The Rat Micturition Reflex |
|
1 | 15:10-15:20 |
Voiding Dysfunction Following Treatment for Cervical Cancer |
|
||||
2 | 15:20-15:30 |
Voiding Dysfunction Following Treatment for Cervical Cancer |
|
||||
3 | 15:30-15:40 |
Voiding Dysfunction Following Treatment for Cervical Cancer |
|
||||
4 | 15:40-15:50 |
Voiding Dysfunction Following Treatment for Cervical Cancer |
|
1 | 15:50-15:55 |
Construction of An Umbrella Cell-Deficient Rat Model and Examination of the Role of Umbrella Cells in Bladder Function. |
|
||||
2 | 15:55-16:00 |
The Development of Pediatric Urodynamics in China and Its Global Contributions |
|
||||
3 | 16:00-16:05 |
Urodynamic Findings of Patients with Detrusor Underactivity Before and During A Trial of Sacral Neuromodulation |
|
||||
4 | 16:05-16:10 |
Endoscopic Enucleation of the Prostate for Benign Prostatic Hyperplasia: Acomparative Analysis Demonstrating Size-Independent Efficacy |
|
||||
5 | 16:10-16:15 |
Sublingual Desmopressin for Nocturnal Polyuria Reduces Fracture and Fall Risk in Older Adults: a Target Trial Emulation |
|
||||
6 | 16:15-16:20 |
The Accessory Nerve from Major Pelvic Ganglion Involves the Regulation of the Bladder Contraction in Rats |
|
||||
7 | 16:20-16:25 |
The Current Status and Future Prospects of the Myogenic Origin of Detrusor Excitability |
|
||||
8 | 16:25-16:30 |
Overactive Bladder in A Fit 29 Year Old Male Following Oral Isotretinoin Therapy for Acne: A Case Study |
|
||||
9 | 16:30-16:35 |
Effects of Visceral Fat Dysfunction on Prostate Enlargement and Lower Urinary Tract Symptoms |
|
||||
10 | 16:35-16:40 |
Neuromodulative Sling to Treat Mixed Urinary Incontinence |
|
1 | 16:40-16:45 |
AI in Functional Urology |
|
||||
2 | 16:45-16:55 |
AI in Functional Urology |
|
||||
3 | 16:55-17:05 |
AI in Functional Urology |
|
||||
4 | 17:05-17:15 |
AI in Functional Urology |
|
1 | 17:15-17:25 |
Risk Factors for Upper Urinary Tract Deterioration in Neurogenic Bladder Patients |
|
||||
2 | 17:25-17:35 |
Risk Factors for Upper Urinary Tract Deterioration in Neurogenic Bladder Patients |
|
||||
3 | 17:35-17:45 |
Risk Factors for Upper Urinary Tract Deterioration in Neurogenic Bladder Patients |
|
||||
4 | 17:45-17:55 |
Risk Factors for Upper Urinary Tract Deterioration in Neurogenic Bladder Patients |
|
1 | 17:55-18:00 |
Thematic Display of Enterprises : Male SUI Current Treatment in China |
|
1 | 12:30-12:33 |
主席致辞 |
|
||||
2 | 12:33-12:35 |
主席致辞 |
|
1 | 12:35-12:45 |
夜尿症诊疗专家经验分享 |
|
||||
2 | 12:45-12:55 |
夜尿症诊疗专家经验分享 |
|
1 | 12:55-13:20 |
问题1:夜尿症作为老年常见疾病,如何使夜尿症疾病诊疗意识在临床和患者中得到进一步普及? 问题2:对于夜尿症或者伴随夜尿症症状的患者,临床如何考虑药物治疗的介入,在患者管理的过程中需要关注哪些问题? 问题3:您认为夜尿症领域药物治疗发展和探索的方向有哪些? |
|
1 | 13:30-13:35 |
Two-Year Outcomes of The Prostatic Urethral Lift in Japan: A Multicenter, Prospective Cohort Study |
|
||||
2 | 13:35-13:40 |
Expression Characteristics and Regulation of Yes-Associated Protein 1 in Mechanosensitive Signaling Pathways involved in Oab |
|
||||
3 | 13:40-13:45 |
Analysis of Clinical Presentation and Videourodynamic Parameter in Female Patients with Dysfunctional Voiding |
|
||||
4 | 13:45-13:50 |
Fully End-To-End Automated Bladder Segmentation and Risk Assessment Based on Bladder Morphology Features for Predicting Upper Urinary Tract Dysfunction |
|
||||
5 | 13:50-13:55 |
LonLong-Term Outcomes of Substitution Urethroplasty for Male Urethral Strictures: A 10-Year Follow-Up and Beyondg-Term Outcomes of Substitution Urethroplasty for Male Urethral Strictures: A 10-Year Follow-Up and Beyond |
|
||||
6 | 13:55-14:00 |
Initial Experience of Pneumovesical Vesicovaginal Fistula Repair Using the Da Vinci SP Robotic System |
|
||||
7 | 14:00-14:05 |
Techniques and Surgical Outcomes of Laparoscopic Repair of Vesicovaginal Fistula |
|
||||
8 | 14:05-14:10 |
Urinary Function and Quality of Life Following Management of Prostate Cancer in Community Dwelling Men: The Concord Health and Ageing in Men (Champ) Project |
|
||||
9 | 14:10-14:15 |
The Experience of Artificial Graft Bladder Augmentation for the Treatment of Interstitial Cystitis |
|
||||
10 | 14:15-14:20 |
Optimization of Sacral Neuromodulation Therapy: Clinical Outcomes and Patient Suitability Exploration of Variable Frequency Mode |
|
||||
11 | 14:20-14:25 |
Functional Ultrasound Imaging of the Pelvic Floor Pre and Post Radical Prostatectomy: Correlation with Long Term Continence Outcomes |
|
||||
12 | 14:25-14:30 |
No-Mesh Treatment for Female Stress Urinary Incontinence |
|
||||
13 | 14:30-14:35 |
Clinical Features, Risk Factors and Sequelae of Detrusor Underactivity: A Study of Possible Cause and Effect |
|
||||
14 | 14:35-14:40 |
Initial experience with robot-assisted extraperitoneal transvesical ureteral reimplantation using Da Vinci SP at a single institution |
|
1 | 14:40-14:45 |
Effects of Curcumin on Pro-Inflammatory Cytokine Suppression in a Novel Inflammation-Induced Urothelium-on-a-Chip Model |
|
||||
2 | 14:45-14:50 |
Which Lower Urinary Tract Dysfunction Factors Were Largely Responsible for Urinary Related Quality of Life Deterioration after Robot-Assisted Radical Prostatectomy? |
|
||||
3 | 14:50-14:55 |
Efficacy and Long-Term Follow-Up of Modified T-Plasty for Bladder Neck Contracture After Prostatectomy via laprocscopic |
|
||||
4 | 14:55-15:00 |
Longitudinal Urodynamic Changes and UTI Risk Factors in Neurogenic Bladder Patients Using Clean Intermittent Catheterization |
|
||||
5 | 15:00-15:05 |
Robotic Sacrocolpopexy with Mesh: Functional and Qol Outcomes with Up To 10 Years Follow-Up |
|
||||
6 | 15:05-15:10 |
Modified Bladder Neck Incision for the Treatment of Women with Underactive Bladder and Chronic Urinary Retention: A One-Year Efficacy Summary |
|
||||
7 | 15:10-15:15 |
Bladder Function and Recurrence Outcomes Following TUC and DMSO Therapy in Hunner-Type Interstitial Cystitis |
|
||||
8 | 15:15-15:20 |
Matrix Stiffness Promotes Proliferation and Fibrosis of Prostatic Fibroblasts through Cytoskeletal Remodeling and Yap1 Activation |
|
||||
9 | 15:20-15:25 |
Urodynamic investigation for Predicting Successful Trial without Catheter in Male Patients with Acute Urinary Retention: A Prospective Study |
|
||||
10 | 15:25-15:30 |
Mid-term outcomes of water vapor thermal therapy (WVTT) for benign prostatic hyperplasia (BPH) in high-risk patients: a retrospective analysis |
|
||||
11 | 15:30-15:35 |
Characteristics of Patients with Recurrent Cystitis and Immunostimulant Use: An Analysis Using Nationwide Claims Data in Korea |
|
||||
12 | 15:35-15:40 |
Prospective Evaluation of Bladder Outlet Obstruction After Radiotherapy and Hormonal Therapy for High-risk Localized and Locally Advanced Prostate Cancer Using Pressure-Flow Studies |
|
||||
13 | 15:40-15:45 |
Research and Development of Implantable Bladder Capacity Monitoring System |
|
||||
14 | 15:45-15:50 |
Can patient satisfaction after intravesical botulinum toxin injection be predicted by preoperative uroflowmetry |
|
||||
15 | 15:50-15:55 |
Revisiting the Role of Platelet-Rich Plasma in SUI: A Systematic Review of Therapeutic Outcomes |
|
||||
16 | 15:55-16:00 |
Clinical Characteristics and Prognosis Analysis of 24 Cases Initially Diagnosed as Interstitial Cystitis But Pathologically Confirmed as Bladder Tumors |
|
1 | 16:00-16:05 |
Voiding dysfunction after Radical Prostatectomy |
|
||||
2 | 16:05-16:10 |
Exploratory Study on The Optimal Exercise Training Model for The Treatment of Overactive Bladder |
|
||||
3 | 16:10-16:15 |
Melatonin pretreated urine derived stem cells-extracellular vesicles regulate clock gene expression and improve nocturia in restrained stress mice |
|
||||
4 | 16:15-16:20 |
Vibegron for overactive bladder in patients 80 years or over (HOKUTO) 2 study |
|
||||
5 | 16:20-16:25 |
Escitalopram Can Reverse Co-Occurring Depression and Overactive Bladder Induced By Corticosterone in Rats. |
|
||||
6 | 16:25-16:30 |
Bladder outlet obstruction after radiation therapy |
|
||||
7 | 16:30-16:35 |
Ultrasound Education and Experience in Urology Trainees in Australia and New Zealand: Progress Over 23 Years |
|
||||
8 | 16:35-16:40 |
Cytokine Ccl7-Mediated Activation of Mesenchymal Stem Cells To Promote Urinary Continence Via Periurethral Fibroblasts Mechanism |
|
||||
9 | 16:40-16:45 |
The Anastomosis of Urethral Stricture: The Experience From Shanghai Sixth People'S Hospital |
|
||||
10 | 16:45-16:50 |
Study on Risk Factors and Predictive Value of Upper Urinary Tract Damage in Female Voiding Dysfunction Patients |
|
||||
11 | 16:50-16:55 |
The Digital Paradigm: Transforming Post-Prostatectomy Incontinence Care Through Comprehensive Management |
|
||||
12 | 16:55-17:00 |
Effect of Sscral Neuromodulation on ChronicPelvic Pain Syndrome |
|
||||
13 | 17:00-17:05 |
Urodynamics: With a Focus on Appropriate Indications |
|
||||
14 | 17:05-17:10 |
The Practice of B Ultrasound Assisted SNM (Stage I) |
|
1 | 17:10-17:15 |
Urinary Dysfunction in Parkinson’S Disease |
|
||||
2 | 17:15-17:20 |
Research on Real-Time Recognition of Urodynamic Signals Based on Yolov5 Model. |
|
||||
3 | 17:20-17:25 |
The management of refractory OAB |
|
||||
4 | 17:25-17:30 |
Transurethral Treatment |
|
||||
5 | 17:30-17:35 |
Voiding dysfunction and antiaging |
|
||||
6 | 17:35-17:40 |
Analysis of Clinical Characteristics of Voiding Dysfunction in Female Patients with Overactive Bladder |
|
||||
7 | 17:40-17:45 |
Effectiveness of Peripheral Electrical Neurostimulation for the Management of Neurogenic Lower Urinary Tract |
|
||||
8 | 17:45-17:50 |
The causal relationship between BMI and polyuria: A Mendelian Randomization Study |
|
||||
9 | 17:50-17:55 |
Linking "Deqi "Intensity to Clinical Outcomes: A Study of Electroacupuncture and Pelvic Floor Muscle Training for Male Stress Urinary Incontinence |
|
||||
10 | 17:55-18:00 |
The BDNF-TrkB-MAPK pathway interacts with peripheral clock genes to circadian bladder function |
|
||||
11 | 18:00-18:05 |
Electroacupuncture alleviates overactive bladder by modulating Piezo2-mediated sensory neurons activity |
|
||||
12 | 18:05-18:10 |
Exploring the Mechanisms of Nocturia Caused by Obstructive Sleep Apnea Syndrome from a Traditional Chinese Medicine (TCM) Viewpoint |
|
||||
13 | 18:10-18:15 |
Modified Surgical Approach for Obstructive Bulbar Urethral Stricture: Ventrally Modified Mucomucosal Anastomotic Non-Transecting Augmentation (MANTA) Urethroplasty—A Report of 5 Cases |
|
||||
14 | 18:15-18:20 |
Sacral Neuromodulation for the Treatment of Lower Urinary Tract Dysfunction: A Singer-Center Study Assessing Predictors of Test Phase Success and Long-Term Efficacy |
|
||||
15 | 18:20-18:25 |
Repeated intravesical platelet-rich plasma injection alleviates symptoms in interstitial cystitis/bladder pain syndrome patients |
|
1 | 08:00-08:30 |
8AG: A Novel Drug Candidate to Manage LUTS / Interstitial Cystitis |
|
||||
2 | 08:30-08:50 |
State-of- Art Lecture: Interstitial Cystitis |
|
||||
3 | 08:50-09:10 |
State-of- Art Lecture:Pelvic Floor Functional Changes after Radical Prostatectomy – Implications for Continence Management |
|
||||
4 | 09:10-09:30 |
State-of- Art Lecture : Neurogenic Bladder Or POP |
|
1 | 09:30-09:40 |
Stagnation in BPH Drug Development: Transparency, Trial Priorities, and Future Directions |
|
||||
2 | 09:40-09:50 |
Rolipram Prevents Detrusor Underactivity Following Pelvic Nerve Crush in Rats by Promoting Nerve Regeneration |
|
||||
3 | 09:50-10:00 |
Machine Learning–Based Risk Stratification for Urinary incontinence in Postmenopausal Women |
|
||||
4 | 10:00-10:10 |
Robotic Female Artificial Urinary Sphincter Implantation: The Initial ANZ Experience |
|
||||
5 | 10:10-10:20 |
Comparative Analysis of Enucleation Techniques for Large Benign Prostatic Hyperplasia ( >80 cm³ ) in Elderly Patients: A Single-Center Cohort Study |
|
||||
6 | 10:20-10:30 |
Surgical Treatment of Urinary Incontinence for Female in China ( History and Present ) |
|
1 | 10:30-10:40 |
The High Apparent Diffusion Coefficient Value of Prostate Causes Lower Urinary Tract Dysfunction |
|
||||
2 | 10:40-10:50 |
Wireless-powered Electrostimulation Implant (WIPES): A Novel Therapeutic Strategy for Mixed Urinary Incontinence |
|
||||
3 | 10:50-11:00 |
Prostatic Calculi Burden and Early Urodynamic Outcomes after Anatomical Endoscopic Enucleation of the Prostate: A Retrospective Single-Center Study |
|
||||
4 | 11:00-11:10 |
Autologous Fascial-Sling and Sphincter Composite for Male Stress Urinary Incontinence Treatment: Surgical Technique and Preliminary Results |
|
||||
5 | 11:10-11:20 |
Comparing Presentation, Risk Factors and Urodynamic Parameters of Detrusor Overactivity with Detrusor Underactivity Between Age Groups |
|
||||
6 | 11:20-11:30 |
Metabolic Syndrome and Its Components as Independent Risk Factors for Nocturia: A National Cross-Sectional Analysis |
|
1 | 11:30-12:00 |
Best Results in Male LUTS Comes from Evidence Based Guidelines |
|
1 | 12:05-12:10 |
Announcement of 2026 and 2027 PPCS Meetings, Legacy item passed between hosts |
|
||||||
2 | 12:10-12:15 |
Address by Organizer of 2026 PPCS |
|
||||||
3 | 12:15-12:20 |
Closing Remarks |
|
1 | 13:00-13:12 |
脊柱外科机器人与3D打印模版辅助在脊髓栓系综合征行骶神经调控精准穿刺的应用比较研究 |
|
||||
2 | 13:12-13:18 |
女性SUI的个体化手术选择:三种术式的短期结局比较 |
|
||||
3 | 13:18-13:24 |
骶神经调控体外测试期程控频率对下尿路尿动力学参数的影响:一项单中心回顾性分析 |
|
||||
4 | 13:24-13:30 |
间质性膀胱炎/膀胱疼痛综合征患者的静息态功能磁共振成像探究 |
|
||||
5 | 13:30-13:36 |
经尿道前列腺等离子电切术后低体温的危险因素及列线图模型建立 |
|
||||
6 | 13:36-13:42 |
基于IC/BPS患者尿液差异代谢产物S1P恢复尿路上皮屏障的研究 |
|
||||
7 | 13:42-13:47 |
讨论 |
1 | 13:47-13:59 |
基质硬度通过骨架重塑激活YAP1驱动前列腺成纤维细胞增殖与纤维化 |
|
||||
2 | 13:59-14:05 |
OLFM4干预SETD1A核质分布以抑制良性前列腺增生进展 |
|
||||
3 | 14:05-14:11 |
穿戴式经皮胫神经调控治疗下尿路症状的真实世界疗效观察 |
|
||||
4 | 14:11-14:17 |
膀胱内A型肉毒毒素注射治疗儿童难治性尿频尿失禁54例分析 |
|
||||
5 | 14:17-14:23 |
铥激光与钬激光前列腺剜除术治疗小体积良性前列腺增生的疗效比较 |
|
||||
6 | 14:23-14:29 |
盆底超声在女性吊带悬吊术后近期并发症诊治中的应用 |
|
||||
7 | 14:29-14:34 |
讨论 |
1 | 14:34-14:46 |
探究骶神经调控对于不同亚群神经源性膀胱合并肾积水患者的上尿路保护效应:一项长达2年随访的多中心研究 |
|
||||
2 | 14:46-14:52 |
经尿道激光前列腺剜除术后膀胱颈挛缩的危险因素分析及预测模型构建 |
|
||||
3 | 14:52-14:58 |
基于网络药理学分析金匮肾气丸治疗肾阳虚型产后压力性尿失禁的机制研究 |
|
||||
4 | 14:58-15:04 |
经皮胫神经电刺激联合米拉贝隆治疗药物难治性膀胱过度活动症的有效性及安全性 |
|
||||
5 | 15:04-15:10 |
改良穿刺点经闭孔无张力尿道中段悬吊术治疗女性压力性尿失禁的长期有效性及安全性研究 |
|
||||
6 | 15:10-15:16 |
A型肉毒毒素治疗下尿路功能障碍的系列研究 |
|
||||
7 | 15:16-15:21 |
讨论 |
1 | 15:21-15:33 |
经尿道蓝激光汽化术治疗良性前列腺增生的疗效及安全性分析 |
|
||||||||
2 | 15:33-15:39 |
PI3K-Akt-mTOR信号通路参与驱动良性前列腺增生 |
|
||||||||
3 | 15:39-15:45 |
基于盆腹动力学下治疗盆腔疼痛 |
|
||||||||
4 | 15:45-15:50 |
讨论 |
|||||||||
5 | 15:50-16:00 |
闭幕式 |
|